Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig W Newcomb

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Journal of Hepatology|April 10, 2014
Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infectionDana D Byrne, Craig W Newcomb, Dean M Carbonari, et al.
Ophthalmology|December 9, 2009
Cyclophosphamide for ocular inflammatory diseasesSiddharth S Pujari, John H Kempen, Craig W Newcomb, et al.
Ophthalmology|June 18, 2011
Risk of relapse in primary acute anterior uveitisLili Grunwald, Craig W Newcomb, Ebenezer Daniel, et al.
International Journal of Behavioral Medicine|July 7, 2009
Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinicsDean G Cruess, A Russell Localio, Alec B Platt, et al.
Ophthalmology|September 15, 2009
Methotrexate for ocular inflammatory diseasesSapna Gangaputra, Craig W Newcomb, Teresa L Liesegang, et al.
American Journal of Ophthalmology|January 1, 2010
Mycophenolate mofetil for ocular inflammationEbenezer Daniel, Jennifer E Thorne, Craig W Newcomb, et al.
American Journal of Ophthalmology|July 3, 2009
Azathioprine for ocular inflammatory diseasesSirichai Pasadhika, John H Kempen, Craig W Newcomb, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2025
Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its SubtypesNicole D Ferrante, Rebecca A Hubbard, Kelley Weinfurtner, et al.
JAMA Network Open|October 31, 2023
Incidence, Microbiological Studies, and Factors Associated With Prosthetic Joint Infection After Total Knee ArthroplastyErica J Weinstein, Alisa J Stephens-Shields, Craig W Newcomb, et al.
BMC Pharmacology & Toxicology|April 19, 2015
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugsM Elle Saine, Dena M Carbonari, Craig W Newcomb, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Hepatology|April 10, 2014
Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infectionDana D Byrne, Craig W Newcomb, Dean M Carbonari, et al.
Ophthalmology|December 9, 2009
Cyclophosphamide for ocular inflammatory diseasesSiddharth S Pujari, John H Kempen, Craig W Newcomb, et al.
Ophthalmology|June 18, 2011
Risk of relapse in primary acute anterior uveitisLili Grunwald, Craig W Newcomb, Ebenezer Daniel, et al.
International Journal of Behavioral Medicine|July 7, 2009
Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinicsDean G Cruess, A Russell Localio, Alec B Platt, et al.
Ophthalmology|September 15, 2009
Methotrexate for ocular inflammatory diseasesSapna Gangaputra, Craig W Newcomb, Teresa L Liesegang, et al.
American Journal of Ophthalmology|January 1, 2010
Mycophenolate mofetil for ocular inflammationEbenezer Daniel, Jennifer E Thorne, Craig W Newcomb, et al.
American Journal of Ophthalmology|July 3, 2009
Azathioprine for ocular inflammatory diseasesSirichai Pasadhika, John H Kempen, Craig W Newcomb, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2025
Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its SubtypesNicole D Ferrante, Rebecca A Hubbard, Kelley Weinfurtner, et al.
JAMA Network Open|October 31, 2023
Incidence, Microbiological Studies, and Factors Associated With Prosthetic Joint Infection After Total Knee ArthroplastyErica J Weinstein, Alisa J Stephens-Shields, Craig W Newcomb, et al.
BMC Pharmacology & Toxicology|April 19, 2015
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugsM Elle Saine, Dena M Carbonari, Craig W Newcomb, et al.
Pageof 6